Patrick J. Perik

1.2k total citations
17 papers, 913 citations indexed

About

Patrick J. Perik is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick J. Perik has authored 17 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick J. Perik's work include HER2/EGFR in Cancer Research (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Peptidase Inhibition and Analysis (4 papers). Patrick J. Perik is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Peptidase Inhibition and Analysis (4 papers). Patrick J. Perik collaborates with scholars based in Netherlands, Switzerland and Germany. Patrick J. Perik's co-authors include Elisabeth G.E. de Vries, Jourik A. Gietema, Dirk J. van Veldhuisen, Winette T.A. van der Graaf, Dirk Th. Sleijfer, Renske Altena, Marjolijn N. Lub–de Hooge, Pieter L. Jager, Jos G. W. Kosterink and M.A. de Korte and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Patrick J. Perik

17 papers receiving 889 citations

Peers

Countries citing papers authored by Patrick J. Perik

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Perik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Perik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Perik more than expected).

Fields of papers citing papers by Patrick J. Perik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Perik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Perik. The network helps show where Patrick J. Perik may publish in the future.

Co-authorship network of co-authors of Patrick J. Perik

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Perik. A scholar is included among the top collaborators of Patrick J. Perik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Perik. Patrick J. Perik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Long-term survival and health-related quality of life after in-hospital cardiac arrest 2021 ·Resuscitation ·(unknown), Sanne E. Hoeks, Michiel J. Blans, Bas van den Bogaard, (unknown), (unknown), Chris Hukshorn, Nardo J. M. van der Meer, (unknown), (unknown), (unknown), Patrick J. Perik, Koen S. Simons, (unknown), Wytze J. Vermeijden, Evert‐Jan Wils, Robert Jan Stolker, Henrik Endeman	10
2	Between-centre differences in care for in-hospital cardiac arrest: a prospective cohort study 2021 ·Critical Care ·Benjamin Gravesteijn, (unknown), Hester F. Lingsma, Robert Jan Stolker, Henrik Endeman, Sanne E. Hoeks, Evert‐Jan Wils, (unknown), Michiel J. Blans, Bas van den Bogaard, (unknown), Chris Hukshorn, Nardo J. M. van der Meer, (unknown), (unknown), (unknown), Patrick J. Perik, (unknown), (unknown), Wytze J. Vermeijden	3
3	¹¹¹In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment 2014 ·Molecular Imaging ·Sietske B.M. Gaykema, Johan R. de Jong, Patrick J. Perik, Adrienne H. Brouwers, Carolien P. Schröder, Thijs H. Oude Munnink, Alphons H.H. Bongaerts, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge	39
4	Cardiovascular toxicity caused by cancer treatment: strategies for early detection 2009 ·The Lancet Oncology ·Renske Altena, Patrick J. Perik, Dirk J. van Veldhuisen, Elisabeth G.E. de Vries, Jourik A. Gietema	193
5	111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity 2007 ·European Journal of Cancer ·M.A. de Korte, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge, P.L. Jager, Jourik A. Gietema, Winette T.A. van der Graaf, W.J. Sluiter, D.J. van Veldhuisen, Thomas Suter, Dirk Th. Sleijfer, Patrick J. Perik	114
6	Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease 2007 ·European Radiology ·(unknown), (unknown), Patrick J. Perik, René A. Tio, Marco Götte, Hans L. Hillege, Rozemarijn Vliegenthart, Janneke B. Houwers, Tineke P. Willems, Matthijs Oudkerk, Felix Zijlstra	14
7	Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity 2007 ·Annals of Oncology ·Patrick J. Perik, Bart Rikhof, Floris A. de Jong, Jaap Verweij, Jourik A. Gietema, Winette T.A. van der Graaf	45
8	Cardiotoxicity associated with the use of trastuzumab in breast cancer patients 2007 ·Expert Review of Anticancer Therapy ·Patrick J. Perik, (unknown), Dirk J. van Veldhuisen, Jourik A. Gietema, Dirk Th. Sleijfer, Elisabeth G.E. de Vries	21
9	Serum HER2 Levels are Increased in Patients with Chronic Heart Failure 2006 ·European Journal of Heart Failure ·Patrick J. Perik, Elisabeth G.E. de Vries, Jourik A. Gietema, Winette T.A. van der Graaf, Tom D.J. Smilde, Dirk Th. Sleijfer, Dirk J. van Veldhuisen	36
10	Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors 2006 ·Acta Oncologica ·Patrick J. Perik, Winette T.A. van der Graaf, Elisabeth G.E. de Vries, Frans Boomsma, (unknown), Dirk J. van Veldhuisen, Dirk Th. Sleijfer, Jourik A. Gietema	21
11	Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer 2006 ·Journal of Clinical Oncology ·Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema, Winette T.A. van der Graaf, M.A. de Korte, S. Jonkman, Jos G. W. Kosterink, Dirk J. van Veldhuisen, Dirk Th. Sleijfer, Pieter L. Jager, Elisabeth G.E. de Vries	235
12	The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients. 2006 ·PubMed ·Patrick J. Perik, Elisabeth G.E. de Vries, Frans Boomsma, (unknown), Dirk J. van Veldhuisen, Dirk Th. Sleijfer, Jourik A. Gietema, Winette T.A. van der Graaf	6
13	Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors. 2005 ·PubMed ·Patrick J. Perik, Elisabeth G.E. de Vries, Frans Boomsma, Winette T.A. van der Graaf, Dirk Th. Sleijfer, D.J. van Veldhuisen, Jourik A. Gietema	21
14	The dilemma of the strive for apoptosis in oncology: mind the heart 2004 ·Critical Reviews in Oncology/Hematology ·Patrick J. Perik, Elisabeth G.E. de Vries, Jourik A. Gietema, Winette T.A. van der Graaf, Dirk Th. Sleijfer, Albert J.H. Suurmeijer, D.J. van Veldhuisen	13
15	Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab 2004 ·British Journal of Pharmacology ·Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik, (unknown), Ly Tran, Joost Bart, Albert J.H. Suurmeijer, Steven de Jong, Pieter L. Jager, Elisabeth G.E. de Vries	136
16	Biodistribution and pharmacokinetics of radiolabeled trastuzumab in HER2-positive metastatic breast cancer 2004 ·Journal of Clinical Oncology ·Marjolijn N. Lub–de Hooge, Patrick J. Perik, Jourik A. Gietema, Piet L. Jager, S. Jonkman, Jos G. W. Kosterink, (unknown), Winette T.A. van der Graaf, Dirk Th. Sleijfer, Elisabeth G.E. de Vries	5
17	Circulating apoptosis-related proteins in long-term disease free breast cancer survivors 2004 ·Journal of Clinical Oncology ·Patrick J. Perik, Elisabeth G.E. de Vries, Dirk J. van Veldhuisen, Winette T.A. van der Graaf, Dirk Th. Sleijfer, Jourik A. Gietema	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact